Eli Lilly weight loss drug retatrutide clears obesity trial
Eli Lilly on Thursday mentioned its next-generation drug cleared a vital late-stage trial in sufferers with obesity, delivering vital weight loss throughout doses. The outcomes convey Lilly one step nearer to submitting for approval of the weekly injection, referred to as retatrutide, which works in a different way from present pictures and tablets from each…
